source
- Novartis CEO says Trump’s drug pricing plan creates a very difficult situation for makers and patientsNovartis chief executive Vas Narasimhan warned that the United States drug‑pricing policy under President Trump presents a "very difficult situation" for both drugmakers and patients. He said the…
- BridgeBio's heart drug Attruby exceeds sales expectations, shifting investor outlookBridgeBio prepared to sell its heart drug Attruby on its own, prompting skepticism from investors and analysts who doubted the company could compete with larger rivals. The drug far outperformed f…